BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 12598526)

  • 1. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity.
    Bach D; Pich S; Soriano FX; Vega N; Baumgartner B; Oriola J; Daugaard JR; Lloberas J; Camps M; Zierath JR; Rabasa-Lhoret R; Wallberg-Henriksson H; Laville M; Palacín M; Vidal H; Rivera F; Brand M; Zorzano A
    J Biol Chem; 2003 May; 278(19):17190-7. PubMed ID: 12598526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of mitofusin-2 expression in skeletal muscle.
    Zorzano A
    Appl Physiol Nutr Metab; 2009 Jun; 34(3):433-9. PubMed ID: 19448711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2.
    Soriano FX; Liesa M; Bach D; Chan DC; Palacín M; Zorzano A
    Diabetes; 2006 Jun; 55(6):1783-91. PubMed ID: 16731843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes.
    Zorzano A; Hernández-Alvarez MI; Palacín M; Mingrone G
    Biochim Biophys Acta; 2010; 1797(6-7):1028-33. PubMed ID: 20175989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?
    Mingrone G; Manco M; Calvani M; Castagneto M; Naon D; Zorzano A
    Diabetologia; 2005 Oct; 48(10):2108-14. PubMed ID: 16160866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
    Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
    Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A form of mitofusin 2 (Mfn2) lacking the transmembrane domains and the COOH-terminal end stimulates metabolism in muscle and liver cells.
    Segalés J; Paz JC; Hernández-Alvarez MI; Sala D; Muñoz JP; Noguera E; Pich S; Palacín M; Enríquez JA; Zorzano A
    Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1208-21. PubMed ID: 23941871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of skeletal muscle mitochondrial content in older adults: relationship between mitochondria, fibre type and high-intensity exercise training.
    Wyckelsma VL; Levinger I; McKenna MJ; Formosa LE; Ryan MT; Petersen AC; Anderson MJ; Murphy RM
    J Physiol; 2017 Jun; 595(11):3345-3359. PubMed ID: 28251664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mitochondrial fission and fusion regulatory proteins in skeletal muscle during chronic use and disuse.
    Iqbal S; Ostojic O; Singh K; Joseph AM; Hood DA
    Muscle Nerve; 2013 Dec; 48(6):963-70. PubMed ID: 23494933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein.
    Holloway GP; Perry CG; Thrush AB; Heigenhauser GJ; Dyck DJ; Bonen A; Spriet LL
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1060-9. PubMed ID: 18349111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low abundance of Mfn2 protein correlates with reduced mitochondria-SR juxtaposition and mitochondrial cristae density in human men skeletal muscle: Examining organelle measurements from TEM images.
    Castro-Sepulveda M; Fernández-Verdejo R; Tuñón-Suárez M; Morales-Zúñiga J; Troncoso M; Jannas-Vela S; Zbinden-Foncea H
    FASEB J; 2021 Apr; 35(4):e21553. PubMed ID: 33749943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons.
    Wang W; Zhang F; Li L; Tang F; Siedlak SL; Fujioka H; Liu Y; Su B; Pi Y; Wang X
    J Biol Chem; 2015 Jan; 290(1):168-82. PubMed ID: 25416777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity.
    Houzelle A; Jörgensen JA; Schaart G; Daemen S; van Polanen N; Fealy CE; Hesselink MKC; Schrauwen P; Hoeks J
    Diabetologia; 2021 Feb; 64(2):424-436. PubMed ID: 33258025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitofusin 2 deficiency leads to oxidative stress that contributes to insulin resistance in rat skeletal muscle cells.
    Nie Q; Wang C; Song G; Ma H; Kong D; Zhang X; Gan K; Tang Y
    Mol Biol Rep; 2014 Oct; 41(10):6975-83. PubMed ID: 25034891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high‑fat diet‑fed rats through AMP‑activated protein kinase signaling.
    Kong D; Song G; Wang C; Ma H; Ren L; Nie Q; Zhang X; Gan K
    Mol Med Rep; 2013 Jul; 8(1):205-10. PubMed ID: 23652351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells.
    Santel A; Frank S; Gaume B; Herrler M; Youle RJ; Fuller MT
    J Cell Sci; 2003 Jul; 116(Pt 13):2763-74. PubMed ID: 12759376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expressing mitofusin-2 in healthy mature mammalian skeletal muscle does not alter mitochondrial bioenergetics.
    Lally JS; Herbst EA; Matravadia S; Maher AC; Perry CG; Ventura-Clapier R; Holloway GP
    PLoS One; 2013; 8(1):e55660. PubMed ID: 23383258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death.
    Huang P; Yu T; Yoon Y
    Eur J Cell Biol; 2007 Jun; 86(6):289-302. PubMed ID: 17532093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mfn2 is Required for Mitochondrial Development and Synapse Formation in Human Induced Pluripotent Stem Cells/hiPSC Derived Cortical Neurons.
    Fang D; Yan S; Yu Q; Chen D; Yan SS
    Sci Rep; 2016 Aug; 6():31462. PubMed ID: 27535796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system.
    Pich S; Bach D; Briones P; Liesa M; Camps M; Testar X; Palacín M; Zorzano A
    Hum Mol Genet; 2005 Jun; 14(11):1405-15. PubMed ID: 15829499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.